Public Profile

Method Pharmaceuticals, LLC

Method Pharmaceuticals, LLC, headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of innovative drug delivery systems. Founded in 2015, the company has rapidly established itself as a leader in the field, focusing on advanced formulations that enhance patient outcomes. With a strong operational presence across North America and Europe, Method Pharmaceuticals is dedicated to providing unique solutions in the areas of injectable medications and specialty pharmaceuticals. Their core products are distinguished by their commitment to quality and efficacy, utilising cutting-edge technology to meet the evolving needs of healthcare providers and patients alike. Recognised for its significant contributions to the industry, Method Pharmaceuticals continues to push the boundaries of pharmaceutical innovation, positioning itself as a trusted partner in the healthcare landscape.

DitchCarbon Score

How does Method Pharmaceuticals, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

13

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

Method Pharmaceuticals, LLC's score of 13 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

80%

Method Pharmaceuticals, LLC's reported carbon emissions

Method Pharmaceuticals, LLC, headquartered in the US, currently does not have any publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the company may still be engaged in sustainability practices typical of the pharmaceutical industry, which often includes efforts to reduce carbon footprints and enhance environmental responsibility. As the industry increasingly focuses on climate commitments, Method Pharmaceuticals may develop strategies in line with global standards to address carbon emissions in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Method Pharmaceuticals, LLC's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Method Pharmaceuticals, LLC is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Method Pharmaceuticals, LLC is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Hikma Pharmaceuticals

GB
Health and social work services (85)
Updated 2 days ago

Par Pharmaceutical, Inc.

US
Chemicals nec
Updated 7 days ago
DitchCarbon Score

Aytu BioPharma, Inc.

US
Health and social work services (85)
Updated 7 days ago

Amneal

US
Fabricated metal products, except machinery and equipment (28)
Updated 5 days ago

Perrigo

IE
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers